Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Saturday. The firm set a “hold” rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Stock Up 5.4 %

Shares of MLSS stock opened at $0.88 on Friday. The business’s fifty day moving average is $0.81 and its 200 day moving average is $0.86. The stock has a market cap of $68.54 million, a price-to-earnings ratio of -12.57 and a beta of 1.10. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10.

Insider Activity at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. The trade was a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 24.75% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Milestone Scientific

A number of institutional investors have recently made changes to their positions in the company. World Investment Advisors LLC purchased a new position in Milestone Scientific in the 3rd quarter worth approximately $91,000. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific in the 3rd quarter worth $48,000. Finally, Geode Capital Management LLC raised its stake in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.